Purpose The structure and functions of the left heart cavities have important prognostic value in heart diseases and heart rate control is among the important treatment goals. In this study, we investigated the effects of heart rate on left heart structure and functions in hypertension patients with normal left ventricular systolic function. Method One-hundred-fifty-three patients were included in the study. The patients were divided into two groups according to their heart rate(70 beats/min and below and above 70 beats/min). Left ventricular and atrial strain analyses were performed in echocardiographic evaluation. Results Patients with a resting heart rate of 70 or less were named group-1(64.2±19), patients with a resting heart rate above 70 were named group-2(79.1±6.8). Left atrial max volüm (60.8±15.5 vs 52.9±16.3 p:0.007), left atrial min volüm(28.8±9.5 vs 22.6±7.9 p < 0.001), left atrial emptying fraction%(52.8±8.5 vs 56.1±8.5 p:0.035), left atrial expansion index (1.19±0.44 vs 1.36±0.47 p:0.044), GLSReLA(-1.3±0.38 vs -1.5±0.61 p:0.031), GLS(-19.3±3 vs. -18.2±2.7 p:0.07) showed difference between group-1 and group-2, respectively. In the multivariable regression analysis, beta-bloker(OR:0.291, 95% CI 0.105–0.810, p:0.018), mean high diastolic blood pressure(OR:1.054, 95% CI 1.009–1.101, p:0.018), left atrial min volume( OR:0.870, 95% Cl 0.809–0.938, p < 0.001), Sm(OR:10.6, 95% CI 1.1–104, p:0.041), left atrial expansion index(OR:0.870, 95% CI 0.809–0.930, p < 0.033) were determined as independent predictors of high resting heart rate. Conclusions Heart rate control emerges as an important goal in patients with hypertension and preserved left ventricular systolic function. Mortality and morbidity can also be improved by the positive effect of heart rate control on GLS.
Background: The structure and functions of the left heart cavities have important prognostic value in heart diseases and heart rate control is among the important treatment goals. Objectives: In this study, we investigated the effects of heart rate on left heart structure and functions in hypertension patients with normal left ventricular systolic function. Methods: This is a single-center, prospective, observational (case-control) study. One hundred fifty-three patients were included in the study. The patients were divided into two groups according to their heart rate (70 beats/min and below and above 70 beats/min). Left ventricular and atrial strain analyses were performed in echocardiographic evaluation. Results: Patients with a resting heart rate of 70 beats/min or less were named group-1(64.2±19), patients with a resting heart rate above 70 beats/min were named group-2(79.1±6.8). Left atrial maximum volüm (60.8±15.5 ml vs. 52.9±16.3 ml p:0.007), left atrial minimum volüm(28.8±9.5 vs. 22.6±7.9 p<0.001), left atrial emptying fraction (52.8±8.5% vs 56.1±8.5% p:0.035), left atrial expansion index (1.19±0.44 vs 1.36±0.47 p:0.044), pLASRcd(-1.3±0.38 vs -1.5±0.61 p:0.031), GLS(-19.3±3 vs. -18.2±2.7 p:0.07) showed difference between group-1 and group-2, respectively. In the multivariable regression analysis, beta-bloker(OR:0.291, 95% CI 0.105-0.810, p:0.018), mean high diastolic blood pressure(OR:1.054, 95% CI 1.009-1.101, p:0.018), left atrial minimum volüme (OR:0.870, 95% Cl 0.809-0.938, p<0.001), S’ (OR:10.6, 95% CI 1.1-104, p:0.041), left atrial expansion index(OR:0.870, 95% CI 0.809-0.930, p<0.033) were determined as independent predictors of high resting heart rate. Conclusions: Heart rate control emerges as an important goal in patients with hypertension and preserved left ventricular systolic function. Mortality and morbidity can also be improved by the positive effect of heart rate control on GLS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.